Human leukocyte antigen class I antibody-activated endothelium promotes CD206+ M2 macrophage polarization and MMP9 secretion through TLR4 signaling and P-selectin in a model of antibody-mediated rejection and allograft vasculopathy

By sjmartinez • February 22, 2024

Nevarez-Mejia J, Jin YP, Pickering H, Parmar R, Valenzuela NM, Sosa RA, Heidt S, Fishbein GA, Rozengurt E, Baldwin WM 3rd, Fairchild RL, Reed EF. Human leukocyte antigen class I antibody-activated endothelium promotes CD206+ M2 macrophage polarization and MMP9 secretion through TLR4 signaling and P-selectin in a model of antibody-mediated rejection and allograft vasculopathy. Am J Transplant. 2023 Oct 29:S1600-6135(23)00822-5. doi: 10.1016/j.ajt.2023.10.020. Epub ahead of print. PMID: 38379280.

Tags: AMR, antibody-mediated rejection, AOIs, areas of interest, cardiac allograft vasculopathy, CAV, Digestive Diseases, donor-specific HLA antibodies, DSA, EC, endothelial cell, HLA, human leukocyte antigen, Publications, transplant vasculopathy, TV

Authors’ Reply on Immune-Mediated Liver Injury in HCC

Ennin E, Mallepally N, Dodge JL, Dara L. Authors' Reply on Immune-Mediated Liver Injury in HCC. Liver Int. 2025 Nov;45(11):e70415. doi: 10.1111/liv.70415. PMID: 41122960.

Changes in Colorectal Cancer Screening Modalities Among Insured Individuals

Siddique S, Wang R, May FP, Baum LVM, Gross CP, Ma X. Changes in Colorectal Cancer Screening Modalities Among Insured Individuals. JAMA Netw Open. 2025[...]

Comparative Efficacy of Advanced Therapies for Management of Moderate-to-Severe Crohn’s Disease: 2025 AGA Evidence Synthesis

Singh S, Murad MH, Yuan Y, Ananthakrishnan AN, Click B, Syal G, Haydek JP, Agrawal M, Kappelman MD, Lewis JD, Scott FI. Comparative Efficacy of[...]